Skip to main content Accessibility help
×
Home

A Cluster of Severe Postoperative Bleeding Following Open Heart Surgery

  • Margarita E. Villarino (a1), Steven M. Gordon (a1), Carol Valdon (a2), Diana Potts (a2), Kevin Fish (a2), Charles Uyeda (a2), Patrick M. McCarthy (a2), Lee A. Bland (a1), Roger L. Anderson (a1) and William R. Jarvis (a1)...

Abstract

Objective:

To investigate a cluster of postoperative bleeding following open heart surgery.

Design:

A cohort and case/control study.

Setting:

Palo Alto Veterans Administration Medical Center, Palo Alto, California.

Participants:

Six (21.4%) of 28 patients undergoing open heart surgery who developed severe, nonsurgical, postoperative bleeding from July 1 through August 30, 1988 (outbreak period). All case-patients had chest tube drainage of > 1000 ml within 4 hours of surgery but did not have identifiable bleeding vessel(s) on exploration.

Results:

Upon comparison of the pre-outbreak (January 1986 through June 1988) and the outbreak period, a significant increase was found in the incidence of postoperative nonsurgical bleeding (5/440 versus 6/28, p = .0006), but not of postoperative surgical bleeding (8/440 versus 0/28, p = 1 .0). Of all patients undergoing open heart surgery during the outbreak period, case patients were found to be older (67.8 versus 60.6, p= .02) and to have received a larger volume of hetastarch (HES), a synthetic colloidal plasma-volume expander (mean = 19.4 ml/kg versus 14.1 ml/kg, p= .02).

Conclusions:

We conclude that the use of large volumes of HES during surgery in the elderly open heart surgery patient may increase the risk for severe, nonsurgical postoperative bleeding, probably caused by alterations of the coagulation system. As the incidence of open heart surgery increases among the elderly, surgeons and anesthesiologists should be alert to possible adverse reactions from exposures not associated with adverse reactions in younger patients.

Copyright

Corresponding author

A-07, Epidemiology Branch, Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control, Atlanta, GA 30333

References

Hide All
1.Belcher, P, Lennox, SC. Avoidance of blood transfusion in coronary artery surgery: a trial of hydroxyethyl starch. Ann Thorac Surg. 1984;37:365370.
2.McCarthy, PM, Popovsky, MA, Schaff, HV, et al. Effect of blood conservation efforts in cardiac operations at the Mayo Clinic. Mayo Clin Proc. 1988;63:225229.
3.Munsch, CM, MacIntyre, E, Machin, SJ, Mackie, IJ, Treasure, T. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg. 1988;75:675678.
4.Hicks, GL, Jensen, LA, Norsen, LH, Quinn, JR, Stewart, SS, DeWeese, JA. Platelet inhibitors and hydroxyethyl starch: safe and cost-effective interventions in coronary artery surgery. Ann Thorac Surg. 1985;39:422425.
5.Symington, BE. Hetastarch and bleeding complications. Ann Intern Med. 1986;105:627628.
6.Cully, MD, Larson, CP, Silverberg, GD. Hetastarch coagulopathy in a neurosurgical patient. Anesthesiology 1987;66:706707.
7.Lockwood, DN, Bullen, C, Machin, SJ. A severe coagulopathy following volume replacement with hydroxyethyl starch in a Jehovah's Witness. Anaesthesia. 1988;43:391393.
8.Siegel, S. Nonparametric Statistics for Behavioral Sciences. New York, NY: John Wiley & Sons; 1981.
9.APHA. Standard Methods for the Examination of Water and Wastewater. New York, NY: APHA; 1960.
10.Booth, C. The limulus amoebocyte lysate (LAL) assay-a replacement for the rabbit pyrogen test. Dev Biol Stand. 1986;64:271273.
11.Harker, LA. Bleeding after cardiopulmonary bypass. N Engl J Med. 1986;314:14461447.
12.Salzman, EW, Weinstein, MJ, Weintraub, RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med. 1986;314: 14021406.
13.Strauss, RG, Stump, DC, Henriksen, A, Saunders, R. Effects of hydroxyethyl starch on fibrinogen. fibrin clot formation, and fibrinolysis. Transfusion. 1984;25:230234.
14.Macintyre, E, Mackie, IJ, Ho, D, Tinker, J, Bullen, C, Machin, SJ. The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander. Intensive Care Med. 1985;11:300303.
15.Kirklin, JK, Lell, WA, Kouchoukos, NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg. 1984;37:4046.
16.Stump, DC, Strauss, RG, Henriksen, RA, Petersen, RE, Saunders, R. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion. 1985;25:349354.
17.Bick, RL. Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits. Semin Thromb Hemost. 1985;11:249280.
18.Strauss, RG. Review of the effects of hydroxyethyl starch on the blood coagulation system. Transfusion. 1981;21:299302.
19.Gonzalez-Santos, JM, Ennabli, K, Pelletier, LC. Coronary artery bypass surgery in the eighth decade of life: experience with 101 patients. Thorac Cardiovasc Surg. 1984;32:341345.
20.Mullany, CJ, Clarebrough, JK, White, AL, Wilson, AC. Open heart surgery in the elderly. Aust NZ J Surg. 1987;57:733737.
21.Silvay, G, Bodner, N, Koffsky, B, Mindich, BP, Litwak, RS, Kaplan, JA. Open heart surgery in patients in the eighth and ninth decades of life. J Am Geriatr Soc. 1988;36:11231124.
22.Hughes, CF, Grant, AF, Leckie, BD, Baird, DK. Cardioplegic solution: a contamination crisis. J Thorac Cardiovasc Surg. 1986;91:296302.
23.Andersen, LW, Baek, L, Degn, H, Lehd, J, Krasnik, M, Rasmussen, JP. Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg. 1987;93:115119.
24.Bland, LE, Villarino, ME, Arduino, MJ, et al. Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during open heart surgery procedures. J Thorac Cardiovasc Surg. [in press].
25.National Center for Health Statistics. National Hospital Discharge Survey. Hyattsville, MD: US Department of Health and Human Services; 1987.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed